We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immunoassay Analyzer Rapidly Assesses Cardiac Markers

By LabMedica International staff writers
Posted on 16 Jul 2012
A fully automated immunoassay analyzer offers a comprehensive cardiac panel. More...
The analyzer also offers markers for coagulation, infection, and pregnancy.

Called the AQT90 FLEX immunoassay analyzer, it utilizes a time-resolved fluorescence method to detect sandwich complexes formed between capture antibodies, europium chelate-labelled fluorescent tracer antibodies, and the antigen of interest.

The analyzer offers quality control and comprehensive system quality checks of every process to ensure that each test is performed error-free, providing accurate results at the point of care. It minimizes background fluorescence and detects small amounts of analyte.

The analyzer is a Radiometer (Crawley, United Kingdom) product. The companies IT systems provide complete remote control of decentrally placed analyzers that emulate the data control and flow of a central laboratory, with the potential to encompass multiple hospitals within a region.

Barnsley Hospital (Barnsley, United Kingdom) has recently installed Radiometer’s AQT90 FLEX analyzer in its emergency department, where it enables rapid assessment of patients presenting with chest pain. Dr James Griffiths, a consultant in emergency medicine at the hospital, described studies using Radiometer’s AQT90 FLEX. He stated that it provided "a closed system that is extremely easy to use; the sample tube is placed directly in the analyzer, eliminating the need for further handling of samples and reagents. Low risk patients undergo cardiac marker assessment on arrival and again at 90 minutes. If the test results and the accompanying electrocardiograms (ECGs) are normal, they can be discharged within four hours, avoiding the 12-hour wait associated with the traditional troponin test. It’s better for the patient, and the benefit to the hospital is that it reduces admissions and relieves pressure on acute care beds."

Related Links:
Radiometer
Barnsley Hospital

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.